AU3584897A - Vaccine to prevent streptococcal endocarditis - Google Patents

Vaccine to prevent streptococcal endocarditis

Info

Publication number
AU3584897A
AU3584897A AU35848/97A AU3584897A AU3584897A AU 3584897 A AU3584897 A AU 3584897A AU 35848/97 A AU35848/97 A AU 35848/97A AU 3584897 A AU3584897 A AU 3584897A AU 3584897 A AU3584897 A AU 3584897A
Authority
AU
Australia
Prior art keywords
vaccine
streptococcal endocarditis
prevent streptococcal
endocarditis
prevent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35848/97A
Other languages
English (en)
Inventor
Dana Burnett-Curley
Francis L. Macrina
Cindy L. Munro
Helen B. Viscount
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virginia Commonwealth University
Original Assignee
Virginia Commonwealth University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Commonwealth University filed Critical Virginia Commonwealth University
Publication of AU3584897A publication Critical patent/AU3584897A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU35848/97A 1996-06-21 1997-06-20 Vaccine to prevent streptococcal endocarditis Abandoned AU3584897A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2017496P 1996-06-21 1996-06-21
US60020174 1996-06-21
PCT/US1997/011329 WO1997048417A1 (fr) 1996-06-21 1997-06-20 Vaccin visant a prevenir l'endocardite streptococcique

Publications (1)

Publication Number Publication Date
AU3584897A true AU3584897A (en) 1998-01-07

Family

ID=21797134

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35848/97A Abandoned AU3584897A (en) 1996-06-21 1997-06-20 Vaccine to prevent streptococcal endocarditis

Country Status (5)

Country Link
EP (1) EP0912193A4 (fr)
JP (1) JP2000514790A (fr)
AU (1) AU3584897A (fr)
CA (1) CA2258011A1 (fr)
WO (1) WO1997048417A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5882871A (en) * 1996-09-24 1999-03-16 Smithkline Beecham Corporation Saliva binding protein
ES2322306T3 (es) 1998-12-21 2009-06-18 Medimmune, Inc. Proteinas de streptpcpccus pneumoniae y fragmentos inmunogenicos para vacunas.
LT6214B (lt) * 2013-10-07 2015-08-25 Uab "Bioseka" Priešprasminiai oligonukleotidai aterosklerozės ir kardiovaskulinių infekcijų prevencijai

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422427A (en) * 1991-09-17 1995-06-06 The United States Of America As Represented By The United States Department Of Health And Human Services Pneumococcal fimbrial protein A
AU3065892A (en) * 1991-11-14 1993-06-15 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Pneumococcal fimbrial protein a vaccines
EP0707651A1 (fr) * 1993-04-26 1996-04-24 University Of Victoria Innovation And Development Corporation PROCEDES ET COMPOSITIONS DE DETECTION DE LA $i(SALMONELLE)

Also Published As

Publication number Publication date
EP0912193A1 (fr) 1999-05-06
JP2000514790A (ja) 2000-11-07
WO1997048417A1 (fr) 1997-12-24
CA2258011A1 (fr) 1997-12-24
EP0912193A4 (fr) 2000-11-02

Similar Documents

Publication Publication Date Title
AU4781297A (en) Vaccines
AU2168597A (en) Improvements in or relating to encapsulation
AU3560497A (en) Anthelmintic formulations
GB9616351D0 (en) Vaccine composition
ZA979984B (en) Vaccine composition
AU6941698A (en) Anti-cancer vaccine
AU4072497A (en) Pillow
AU3038697A (en) Meningococcal vaccine
AU6715094A (en) Recombinant vaccine
AU3552797A (en) Vaccine preparations
AU3584897A (en) Vaccine to prevent streptococcal endocarditis
AU5065698A (en) Improvements to gas-masks
AU5597998A (en) Recombinant plague vaccine
AU6075498A (en) Vaccines
AU3452997A (en) Vaccine compositions
AU2027297A (en) Immunity to trypanosomatids species
AU1656097A (en) Cork tile application
AUPO526497A0 (en) Enzootic pneumonia vaccine
AUPN824596A0 (en) Enzootic pneumonia vaccine
AUPO206496A0 (en) Improvements to chairs
AUPO189896A0 (en) Improvements to chairs
AU1111600A (en) Virtual prospecting using e-commercials
AUPN745196A0 (en) Vaccine for porcine enzootic pneumonia
AU5812898A (en) Polyoxime-based anti-malarial vaccines
AU6293896A (en) Sarcocystis vaccine

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted